Susanne Marschner Terumo BCT Scientific Affairs Biography Publications Institution JoVE Articles Susanne Marschner has not added a biography. If you are Susanne Marschner and would like to personalize this page please email our Author Liaison for assistance. Publications Transfusion of Human Platelets Treated with Mirasol Pathogen Reduction Technology Does Not Induce Acute Lung Injury in Mice PloS One. 2015 | Pubmed ID: 26176623 Inactivation of Viruses in Platelet and Plasma Products Using a Riboflavin-and-UV-based Photochemical Treatment Transfusion. Jul, 2015 | Pubmed ID: 25731607 Observational Study of Corrected Count Increments After Transfusion of Platelets Treated with Riboflavin Pathogen Reduction Technology in Additive Solutions Transfusion. Jul, 2015 | Pubmed ID: 25702711 Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure in Multiple Myeloma Patients Journal of Clinical Apheresis. Feb, 2015 | Pubmed ID: 24941931 Riboflavin and Ultraviolet Light for Pathogen Reduction of Murine Cytomegalovirus in Blood Products Transfusion. Dec, 2014 | Pubmed ID: 25438832 Immune Modulation and Lack of Alloimmunization Following Transfusion with Pathogen-reduced Platelets in Mice Transfusion. Mar, 2013 | Pubmed ID: 23451715 Development of a Riboflavin and Ultraviolet Light-based Device to Treat Whole Blood Transfusion. Jan, 2013 | Pubmed ID: 23301965 Treatment of Whole Blood with Riboflavin Plus Ultraviolet Light, an Alternative to Gamma Irradiation in the Prevention of Transfusion-associated Graft-versus-host Disease? Transfusion. Feb, 2013 | Pubmed ID: 22612327 The Inositol 5-phosphatase SHIP-1 and Adaptors Dok-1 and 2 Play Central Roles in CD4-mediated Inhibitory Signaling Immunology Letters. Mar, 2012 | Pubmed ID: 22370159 In Vitro Quality of Single-donor Platelets Treated with Riboflavin and Ultraviolet Light and Stored in Platelet Storage Medium for Up to 8 Days Transfusion. May, 2012 | Pubmed ID: 22014032 Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie. 2011 | Pubmed ID: 21779202 In Vivo Viability of Stored Red Blood Cells Derived from Riboflavin Plus Ultraviolet Light-treated Whole Blood Transfusion. Jul, 2011 | Pubmed ID: 21275998 Inactivation of Human White Blood Cells in Platelet Products After Pathogen Reduction Technology Treatment in Comparison to Gamma Irradiation Transfusion. Jul, 2011 | Pubmed ID: 21155832 Generation of Neutrophil Priming Activity by Cell-containing Blood Components Treated with Pathogen Reduction Technology and Stored in Platelet Additive Solutions Transfusion. Jun, 2011 | Pubmed ID: 21155831 The Mirasol Pathogen Reduction Technology System and Quality of Platelets Stored in Platelet Additive Solution Blood Transfusion = Trasfusione Del Sangue. Jul, 2010 | Pubmed ID: 20671879 White Blood Cell Inactivation After Treatment with Riboflavin and Ultraviolet Light Transfusion. Nov, 2010 | Pubmed ID: 20529002 Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie. 2009 | Pubmed ID: 21076549 Lack of Antibody Formation to Platelet Neoantigens After Transfusion of Riboflavin and Ultraviolet Light-treated Platelet Concentrates Transfusion. Dec, 2009 | Pubmed ID: 19694996 Understanding Loss of Donor White Blood Cell Immunogenicity After Pathogen Reduction: Mechanisms of Action in Ultraviolet Illumination and Riboflavin Treatment Transfusion. Dec, 2009 | Pubmed ID: 19682337 Treatment with Riboflavin and Ultraviolet Light Prevents Alloimmunization to Platelet Transfusions and Cardiac Transplants Transplantation. Nov, 2007 | Pubmed ID: 17998874 A Human CD4 Monoclonal Antibody for the Treatment of T-cell Lymphoma Combines Inhibition of T-cell Signaling by a Dual Mechanism with Potent Fc-dependent Effector Activity Cancer Research. Oct, 2007 | Pubmed ID: 17942927 CXCR4 Engagement is Required for HIV-1-induced L-selectin Shedding Blood. Feb, 2004 | Pubmed ID: 14576059 Ligation of Human CD4 Interferes with Antigen-induced Activation of Primary T Cells Immunology Letters. Jun, 2002 | Pubmed ID: 12008044 Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination Shawn D. Keil1, Nick Hovenga1, Denise Gilmour1, Susanne Marschner1, Raymond Goodrich1 1Terumo BCT, Scientific Affairs JoVE 52820 Immunology and Infection
Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination Shawn D. Keil1, Nick Hovenga1, Denise Gilmour1, Susanne Marschner1, Raymond Goodrich1 1Terumo BCT, Scientific Affairs JoVE 52820 Immunology and Infection
